Barrow Robert's Form 4 filing
Definium Therapeutics, Inc. (DFTX) · filed Jun 27, 2023
- Accession no.
- 0000950170-23-030256
- Filed
- Jun 27, 2023
- Trade date
- Jun 27, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $49.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barrow RobertCIK 0001897557 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | Common Shares | SSaleDisposed | −7,086 | $3.19 | −$22,604.34 | 631,873 | Direct | |
| Jun 27, 2023 | Common Shares | SSaleDisposed | −8,416 | $3.21 | −$27,015.36 | 623,457 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.